Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation.

Izcue A, Coombes JL, Powrie F.

Immunol Rev. 2006 Aug;212:256-71. Review.

PMID:
16903919
2.
4.
5.

The global burden of typhoid fever.

Crump JA, Luby SP, Mintz ED.

Bull World Health Organ. 2004 May;82(5):346-53.

6.

Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.

Tacket CO, Pasetti MF, Sztein MB, Livio S, Levine MM.

J Infect Dis. 2004 Aug 1;190(3):565-70. Epub 2004 Jun 30.

PMID:
15243933
7.

T- and B-cell immune responses of patients who had undergone colectomies to oral administration of Salmonella enterica serovar Typhi Ty21a vaccine.

Kilhamn J, Lundin SB, Brevinge H, Svennerholm AM, Jertborn M.

Clin Diagn Lab Immunol. 2003 May;10(3):426-30.

8.

Concomitant induction of CD4+ and CD8+ T cell responses in volunteers immunized with Salmonella enterica serovar typhi strain CVD 908-htrA.

Salerno-Gonçalves R, Wyant TL, Pasetti MF, Fernandez-Viña M, Tacket CO, Levine MM, Sztein MB.

J Immunol. 2003 Mar 1;170(5):2734-41.

10.
11.

Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.

Tacket CO, Galen J, Sztein MB, Losonsky G, Wyant TL, Nataro J, Wasserman SS, Edelman R, Chatfield S, Dougan G, Levine MM.

Clin Immunol. 2000 Nov;97(2):146-53.

PMID:
11027455
12.
13.

Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity.

Rininsland FH, Helms T, Asaad RJ, Boehm BO, Tary-Lehmann M.

J Immunol Methods. 2000 Jun 23;240(1-2):143-55.

PMID:
10854609
14.

Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers.

Tacket CO, Sztein MB, Wasserman SS, Losonsky G, Kotloff KL, Wyant TL, Nataro JP, Edelman R, Perry J, Bedford P, Brown D, Chatfield S, Dougan G, Levine MM.

Infect Immun. 2000 Mar;68(3):1196-201.

15.

Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain.

Samandari T, Kotloff KL, Losonsky GA, Picking WD, Sansonetti PJ, Levine MM, Sztein MB.

J Immunol. 2000 Feb 15;164(4):2221-32.

16.

Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam.

Kossaczka Z, Lin FY, Ho VA, Thuy NT, Van Bay P, Thanh TC, Khiem HB, Trach DD, Karpas A, Hunt S, Bryla DA, Schneerson R, Robbins JB, Szu SC.

Infect Immun. 1999 Nov;67(11):5806-10.

17.

Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine.

Levine MM, Ferreccio C, Abrego P, Martin OS, Ortiz E, Cryz S.

Vaccine. 1999 Oct 1;17 Suppl 2:S22-7.

PMID:
10506405
18.
19.

Supplemental Content

Support Center